42nd Annual J.P. Morgan Healthcare Conference

The Genmab Model Genmab Deep insight into antibody biology & disease targets Match in-house expertise with strategic collaborations & partnerships Proprietary technologies enable us to build a world-class pipeline Strong pipeline of potential 1st-in-class/ best-in-class products Genmab 2024 For Investor audience only. Not for public information or use. Not for promotional use. 5

View entire presentation